£50 for 45 minute interview: Leeds/London, aged 12-22 or parents

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

Acumen Fieldwork are looking for the following participants:

  • adolescents (aged 12 – 22) with type 1 or type 2 diabetes
  • parents of children with type 1 or type 2 diabetes

to give feedback on  the design of a new blood glucose device, in these 2 locations:

Leeds (LS1) –  Friday 19th May

London (WC2) – Monday 22nd, Tuesday 23rd , Wednesday 24th May

Interviews are one to one and will last for 45 minutes, participants will be paid £50 as a thank you for their time

Participants will be asked to give feedback on a new blood glucose device and will be asked to demonstrate using a blood glucose meter with simulation blood (no finger pricking is involved)

 

Anyone who is interested in taking part can call Vicki Moran on 0161 242 5215 or email her on vicki.moran@acumenfieldwork.com for more information. Vicki will run though a few screening questions before confirming anyone on to the research.

Posted in Market research | Comments Off on £50 for 45 minute interview: Leeds/London, aged 12-22 or parents

Market research: CGM users or Accu-Chek Mobile users, various locations

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

Acumen Fieldwork are looking for participants in various locations.

Anyone who is interested in taking part can call Vicki Moran on 0161 242 5215 or email her on vicki.moran@acumenfieldwork.com for more information. Vicki will run though a few screening questions before confirming anyone on to the research.

ACCU-CHEK MOBILE USERS

London (WC2): Monday 22nd , Tuesday 23rd  or Wednesday 24th May  (various times available)

Leeds (Wednesday 17th May – Friday 19th May)

and Manchester (Monday 15th – Tuesday 16th May)

Adults and Adolescents  (aged 12+) using Accu-Chek Mobile

Plus Caregivers- providing care for someone who has been diagnosed with Type 1 or Type 2 diabetes using Accu-Chek Mobile such as performing the majority of BG measurements for them (the person they are providing care for will not be required to attend)

Interviews are one to one and will last for 45 minutes, participants will be paid £50 as a thank you for their time

Participants will be asked to give feedback on a new blood glucose device and will be asked to demonstrate using a blood glucose meter with simulation blood (no finger pricking is involved)

CGM USERS

London (EC1V): Thursday 11th May or Friday 12th May (various times available)

Bristol (Monday 15th May, Tuesday 16th May)

and Manchester (Monday 8th May, Tuesday 9th May, Wednesday 10th May)

Adults and Adolescents (aged 12+)  with CGM inserter experience

Interviews and will last 75 minutes, participants will be paid £90 as a thank you for their time

One to one interviews with diabetes patients to inform the design of inserter devices intended to be used as part of a continuous glucose monitoring system. During the session participants will be asked to demonstrate the use of the devices by trialling prototypes on a protective skin belt.

———-

Anyone who is interested in taking part can call Vicki Moran on 0161 242 5215 or email her on vicki.moran@acumenfieldwork.com for more information. Vicki will run though a few screening questions before confirming anyone on to the research.

 

Posted in Market research | Comments Off on Market research: CGM users or Accu-Chek Mobile users, various locations

Now closed: Any CGM or FreeStyle Libre users in Sweden

Please help us find 50 people in Sweden to take part in market research.

Participants must be using either FreeStyle Libre or any CGM. They will be rewarded with a £15 Amazon.co.uk voucher for screening in and completing the 8 minute questionnaire.

As always, INPUT will also receive a reward for helping to find participants.

To take part, click here: sorry, no more participants are needed

 

Posted in Market research | Comments Off on Now closed: Any CGM or FreeStyle Libre users in Sweden

MHRA Medical Device Alert: All Accu-Chek® Insight insulin pumps – updated information for battery management

2 May 2017

Manufactured by Roche Diabetes Care – Replacement and update to MDA/2015/029 with new instructions to improve battery lifetime and prevent unexpected pump shut down or rapid battery depletion. – click on this headline to see the full notice.

Action

  • Identify all users of Accu-Chek Insight insulin pumps.
  • Ensure that all patients and carers:
    • Receive the manufacturer’s Field Safety Notice (FSN)
    • understand the problem detailed in the FSN and follow the advice given by the manufacturer
    • use Energizer® Ultimate lithium batteries (1.5V AAA / FR03) provided by the manufacturer and follow the steps described in the handling instructions in the FSN
  • Contact Roche if you experience unexpected pump shut down or rapid battery depletion.
  • Return the FSN acknowledgment form to Roche as currently the manufacturer hasn’t received enough responses.

 

Posted in MHRA Alerts | Comments Off on MHRA Medical Device Alert: All Accu-Chek® Insight insulin pumps – updated information for battery management

Now closed: T1 Adults on MDI, or Medtronic / OmniPod pumps

We have been asked to help find a few people for market research.

They are looking for:

  • 14 adults (over 18) with Type 1 diabetes currently on a multiple daily injections (3 or more per day)
  • 5 adults (over 18) with Type 1 currently using a Medtronic MiniMed pump
  • 7 adults (over 18) with Type 1 currently using an OmniPod

The interviews will take place on 21st. 22nd and 23rd March in London. They will last 60 minutes and you will be paid £65 as an incentive.

To participate: sorry, no more participants are needed

As always, INPUT will also earn a fee for putting you in touch so please mention INPUT when you email.

Posted in Market research | Comments Off on Now closed: T1 Adults on MDI, or Medtronic / OmniPod pumps

Now closed: FreeStyle Libre user survey in UK, Germany, France & Sweden

We have been asked to find Libre users in the UK, France, Germany and Sweden to complete a survey. Adults and parents of under 18’s can all take part.

The survey will take around 20 minutes, and you will receive a £15 Amazon voucher for completing it. You will need to provide your email address at the end of the survey in order to receive your voucher.

We are looking for big numbers:

  • 110 UK participants
  • 110 participants in Germany
  • 110 participants in France
  • 50 participants in Sweden

As always, INPUT will also receive a donation for each participant recruited through our social media channels. These ‘finders fees’ help us to keep running, so we are very grateful to anyone who takes part.

To see if you are eligible and take the survey click on the following links:

 

*** Survey closed ***

Posted in Market research | Comments Off on Now closed: FreeStyle Libre user survey in UK, Germany, France & Sweden

DIaMonD study suggests CGM helps those on MDI

Two randomised controlled trials, recently published in the Journal of American Medicine Association (JAMA), suggest that Controlled Glucose Monitoring (CGM) greatly benefits people with type 1 diabetes (T1) who use multiple daily insulin injections (MDI), and not only the minority using insulin pumps.

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes)  and GOLD studies, the first to focus solely on the benefits of CGM for adult T1s who use MDIs, were commissioned by Dexcom, and conducted in the US and Sweden respectively.

While CGM is currently used mostly by T1 patients using an insulin pump, the study results prove the system to be both beneficial and user-friendly to those on MDIs. A minority of T1 patients use an insulin pump in the UK.

Results of both trials show that Dexcom’s CGM improves HbA1c levels more than conventional treatment; the device can be used directly for making diabetes treatment decisions instead of alerting patients to use a blood glucose monitor to determine treatment.

Study findings also reveal that CGM also helps detect hypoglycaemic episodes, resulting in fewer such attacks and their inherent risks.

The Dexcom CGM system was the first produced worldwide to interact with mobile phones, and may be used with both Android and iOS smartphones, with the need for only two finger stick checks daily.

The system is available in the UK to both T1 patients and those with Type 2 diabetes who are insulin dependent.

Posted in News | Comments Off on DIaMonD study suggests CGM helps those on MDI

Now closed: 6 pump users aged 18+ for market research focus group

INPUT has been contacted by a market research company organising a half-day long focus group of adult (age 18+) insulin pump users. This small focus group will take place in Central London (exact location to be arranged).

Specifically, they want to speak with:

  • Two long-term (10 years+) pump users who have switched makes of pump (this means from one company to another, rather than different pumps from the same company)
  •  Two newish pump users who got their pump in the past 2 years
  •  One OmniPod user who has switched from another make of pump to their current OmniPod

The event will take place from 12-5pm, with lunch provided, on one of the following dates, depending on what’s best for the participants: Tuesday 28th Feb, or Saturday 4th March.

The incentive? Your travel expenses (up to a maximum £50) will be reimbursed, lunch will be provided, and you’ll get to spend the afternoon with a group of other pump users. Crucially, INPUT will receive a donation of up to £1,350 for finding participants. We are very grateful to those who chose to donate an afternoon of their time to help this project and therefore trigger a huge donation to INPUT.

Thank you for your interest – all spaces have now been filled.

Posted in Market research | Comments Off on Now closed: 6 pump users aged 18+ for market research focus group

INPUT’s Lesley Jordan in Diabetes Times

The latest edition of Diabetes Times includs an interview with INPUT’s Chief Exec Lesley Jordan. Read the interview here.

Posted in News | Comments Off on INPUT’s Lesley Jordan in Diabetes Times

Consultation / care planning tool

Are you fully involved in your care planning? Do you feel there’s more to good diabetes management than a ‘good’ HbA1c?

As part of their comprehensive commissioning pack, the London Diabetes Clinical Network includes a type 1 care consultation tool (developed by Health Innovation Network and King’s Health Partners), which can be used in the management of people with type 1 diabetes.

The Type 1 Diabetes Consultation Tool will help the person with diabetes (PWD) and the consultant to plan individualised care where the patient is fully involved in the process.

The first page is completed by the PWD either before they attend clinic or in the waiting room. It asks the user to note down things such as specific issues they wish to discuss, hypo awareness, confidence in carbohydrate counting, and the burden of diabetes.

Pages 2 and 3 will be completed by the PWD and consultant. Page 2 covers everything that should be in an annual review. Page 3 plots a comprehensive picture of their diabetes control, noting HbA1c along with hypo risk and living with diabetes (or diabetes distress score). There is space for treatment decisions and plans to be noted down. The consultant then takes a copy of the tool, leaving the original with the PWD to take home.

3 point dart board

As we mention in our Better Clinic Appointments page, decisions made in an appointment might be remembered differently by the doctor/nurse and the PWD, so this tool will help solve that problem. It also makes clear that a good HbA1c alone is not the mark of successful diabetes management.

If you think this tool might help your clinic appointments, why not print this page and show your clinic? Experience amongst staff in the London Diabetes Clinical Network shows that whilst it initially takes a little longer for an appointment, it gathers all the data that should be kept anyway, and soon becomes a welcome tool for efficient and high quality care. They suggest a clinic trials the tool with a few PWD before adopting it for every PWD with type 1.

A note of caution: the living with diabetes (or diabetes distress score) section will help clinicians who are not psychologists to spot distress which may have impact on the PWD’s glycaemic control. Many issues can be suitably managed by handling this well in the consultation room. However, if issues are identified which need psychology assessment and support, it would be unfair to uncover these issues and not act on them. The tool is based on research and referenced so that clinicians can make a considered decision on whether or not to adopt it and how to do so safely.

The explanation sheet for PWD can be found here.

The consultation tool is here.

The full commissioning pack is here.

 

 

Posted in Service improvement | Comments Off on Consultation / care planning tool